Navigating the dynamic world of stock markets, especially in the United States, can be both thrilling and challenging. Discover the top-performing stocks that have been making waves in the US market. In this blog, we'll explore the companies and sectors that have been driving success, providing insights into the trends and factors behind their impressive performance. Whether you're an investor seeking opportunities or simply curious about the economic landscape, this guide will shed light on the standout stars of the US stock market.

Top Performing Stocks in the US

The following list comprises the top 10 best-performing stocks of 2023 on major U.S. exchanges, with market capitalizations exceeding $1 billion. Returns are calculated through October 31st.

Overview - Top Performing US Stocks

Certainly, here's a more detailed overview of each of the ten companies and what contributed to their remarkable year-to-date (YTD) returns in 2023:

Carvana Co. (CVNA)

Carvana is an online platform for used car sales, offering direct home delivery to buyers. Despite the company's poor business performance, its YTD return of 469.6% was primarily driven by social media traders and a short squeeze, drawing significant attention and boosting the stock's value.

MoonLake Immunotherapeutics (MLTX)

MoonLake Immunotherapeutics is a clinical-stage biotechnology company focused on developing sonelokimab for treating inflammatory diseases. Positive mid-stage trial results for hidradenitis suppurativa and encouraging 24-month data contributed to its remarkable 393.4% YTD return.

AppLovin Corp. (APP)

AppLovin provides software for app developers, facilitating app discovery and monetization. Its steady YTD return of 246.1% was influenced by strong financial performance, with software platform revenue reaching a record high of $406 million and the successful launch of AXON 2.0, an AI-based advertising engine.

BridgeBio Pharma Inc. (BBIO)

BridgeBio Pharma is a biopharmaceutical company specializing in treating genetic diseases and cancers with single genetic drivers. Positive results from its phase 2 trials for infigratinib and phase 3 data for acoramidis in treating transthyretin amyloid cardiomyopathy played a key role in its remarkable YTD return of 241.7%.

ImmunoGen Inc. (IMGN)

ImmunoGen is a biotech company focused on cancer treatment using antibody-drug conjugates. Positive phase 3 trial data for Elahere in ovarian cancer and robust sales performance, generating $106.9 million in revenue, contributed to its substantial 199.6% YTD return.

MicroStrategy Inc. (MSTR)

MicroStrategy is known for its business intelligence software platform and its significant investment in Bitcoin. With 152,800 BTC on its balance sheet, valued at nearly $5.3 billion, and Bitcoin's YTD increase of about 109%, MicroStrategy shares surged, resulting in a 199.1% YTD return.

Super Micro Computer Inc. (SMCI)

Super Micro Computer produces a wide range of computer hardware products, including servers and networking equipment. Its YTD return of 191.7% was fueled by exposure to high-growth tech fields, with a 37% revenue growth in fiscal 2023, including a 32.9% YoY revenue growth in the fourth quarter.

Riot Platforms Inc. (RIOT)

Riot Platforms is a Bitcoin mining company. In 2022, cryptocurrency-related stocks faced challenges, but in 2023, Bitcoin's 108.8% YTD increase reignited interest. Riot reported 1,775 Bitcoins produced in the second quarter and holds over 7,265 BTC on its balance sheet, resulting in an 188.5% YTD return.

Vertiv Holdings Co. (VRT)

Vertiv produces power and thermal management solutions, mainly for data center customers. Investors bet on the increasing data center workloads needed for AI models, leading to an impressive YTD return of 187.5%. Strong revenue growth, an 18% third-quarter revenue increase, and raised profit guidance further fueled this growth.

Structure Therapeutics Inc. (GPCR)

Structure Therapeutics is a clinical-stage biopharmaceutical company focused on developing GSBR-1290, a daily pill for treating obesity. Positive trial data and the convenience of daily pill administration compared to injectable alternatives led to an 185.8% YTD return.

These companies' YTD returns reflect various factors, from positive trial results to innovative approaches, market trends, and investor enthusiasm, each contributing to their remarkable growth.

The Bottom Line

In summary, the year 2023 has witnessed remarkable stock performance from a diverse set of companies, each propelled by unique catalysts. From online car sales to biotech breakthroughs, data center solutions to cryptocurrency mining, these companies have defied market challenges and leveraged opportunities to deliver outstanding year-to-date returns. Investors, both seasoned and novice, have been drawn to these stocks for their potential and the promises they hold. While the path to these remarkable gains may differ, one thing is clear: the world of investments remains dynamic, offering opportunities for those willing to explore and embrace change. As we navigate the complexities of the stock market, it's essential to stay informed, stay vigilant, and continue seeking growth and success in our investment journeys.

Follow us on Instagram.